A significant advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital tumor protector protein is frequently disabled in several forms of tumors, causing https://socialioapp.com/story6834865/vhh-fragments-reactivate-tumor-suppressor-p53-new-new-approach-for-cancer-management